Driving Innovation in Diagnostics and Life-Saving Medical Devices
Abbott Laboratories, headquartered in Illinois, has built a worldwide reputation for advancing healthcare through science-driven innovation in medical technology. Abbott, which was founded in 1888, has continuously changed the healthcare industry with a broad range of goods, such as nutritional items, diabetes care solutions, cardiovascular equipment, and diagnostic instruments.
By 2025, Abbott will still be leading the way in minimally invasive cardiac implants, point-of-care technology, and quick diagnostic tests. The company’s ID NOW™ platform, a portable molecular testing system, gained major recognition during the COVID-19 pandemic and continues to play a vital role in fast, on-site infectious disease detection.
Abbott also leads in diabetes care with its Free Style Libre, a continuous glucose monitoring (CGM) system that is transforming how patients manage their blood sugar. By combining user-friendly design with clinical precision, Abbott delivers trusted solutions used both in hospitals and at home.
Through ongoing investment in clinical trials, research, and global health initiatives, Abbott demonstrates an unwavering commitment to delivering safe, effective, and accessible healthcare worldwide.
📊 Abbott’s Medical Equipment Revenue by Segment (2024)
-
Diagnostic Testing: USD 5.7B
-
Cardiovascular Devices: USD 4.3B
-
Diabetes Care: USD 4.1B
-
Neuromodulation & Others: USD 2.5B
Source: Abbott Annual Report 2024
You must be logged in to post a comment.